Skip to content
Review

Young patients with hepatocellular carcinoma beyond Milan criteria had higher early recurrence and poorer long-term outcomes after hepatectomy.

Aug 2026 · Hepatobiliary & Pancreatic Diseases International · 0 citations · 25 references
Medicine

TL;DR

Young patients with HCC, particularly those beyond Milan criteria, were at increased risk of early recurrence and poorer long-term outcomes, and these findings support the need for closer surveillance and tailored treatment strategies in this population.

Abstract

Background

Hepatocellular carcinoma (HCC) in young patients is uncommon, and their postoperative prognosis remains poorly defined. This study aimed to evaluate the impact of young age on tumor characteristics, recurrence, and long-term outcomes after hepatectomy in patients with HCC.

Methods

We reviewed 5465 patients who underwent curative-intent hepatectomy for HCC at Asan Medical Center between December 2008 and March 2019. Patients were categorized into younger (< 40 years, n = 265) and older (≥ 40 years, n = 5200) groups. Clinicopathological characteristics, recurrence rates, overall survival (OS), and recurrence-free survival (RFS) were compared between groups before and after 1:10 propensity score matching (PSM). Multivariate logistic regression analysis was performed to identify independent predictors of 2-year recurrence.

Results

Younger patients were more likely to have hepatitis B virus-related HCC (81.1% vs. 65.3%, P < 0.001) and a lower prevalence of cirrhosis (38.5% vs. 45.9%, P = 0.018), and they exhibited a higher 2-year recurrence rate than older patients (39.6% vs. 31.7%, P = 0.007). Among patients within Milan criteria, younger patients showed superior OS (P = 0.028) and RFS (P = 0.013). In contrast, among patients beyond Milan criteria, younger patients had significantly poorer OS (P < 0.001) and RFS (P = 0.003) compared with older patients. These patterns persisted after PSM. Multivariate analysis identified age < 40 years as an independent predictor of 2-year recurrence in the beyond Milan criteria group, but not in the within Milan criteria group.

Conclusions

Young patients with HCC, particularly those beyond Milan criteria, were at increased risk of early recurrence and poorer long-term outcomes. These findings support the need for closer surveillance and tailored treatment strategies in this population.

View source

Similar papers

Open access Sep 2026

Clinical features, treatment patterns, and outcomes of young-onset hepatocellular carcinoma: a tertiary cohort analysis with a nationwide population-based study.

Background/Aims Hepatocellular carcinoma (HCC) in younger patients is uncommon, and its clinical behavior and prognosis remain unclear. We aimed to evaluate the characteristics, treatment patterns, and outcomes of young-onset HCC using large-scale datasets. Methods This study analyzed two cohorts: the Asan Medical Ce...

Eunju Kim, Min Young Kim, Jina Park et al. · 0 citations
Review Sep 2026

Risk-Stratified Surveillance for Recurrent Hepatocellular Carcinoma After Liver Transplantation: A Comparison With the RETREAT-Guided Surveillance Protocol.

BACKGROUND Hepatocellular carcinoma (HCC) recurrence after liver transplantation (LT) is uncommon but associated with poor outcomes, requiring effective surveillance. We assessed adherence to and effectiveness of a risk-stratified surveillance protocol and compared it with the RETREAT-guided surveillance protocol. ME...

I. Dharia, Emily A. Leven, Natalia Schmidt et al. · 0 citations
Sep 2026

Early recurrence predicts survival in patients with 10 or more bilobar colorectal liver metastases: A LASSO regression-based nomogram model.

INTRODUCTION Parenchymal-sparing one-stage hepatectomy (POSH) has expanded surgical eligibility for patients with high-burden (≥10) colorectal liver metastases (CLM). Early recurrence (ER), defined as recurrence within 6 months, remains a challenge, and its prognostic significance and preoperative predictability in thi...

F. Milana, F. Procopio, G. Rodda et al. · 0 citations
Open access Aug 2026

Combined hepatocellular-cholangiocarcinoma shows distinct recurrence patterns and poorer postoperative outcomes compared to hepatocellular carcinoma

Combined hepatocellular–cholangiocarcinoma (cHCC-CCA) is an uncommon primary liver cancer with distinct histology but overlapping clinical features with hepatocellular carcinoma (HCC). This study compared postoperative outcomes between cHCC-CCA and HCC in patients with very-early or early-stage tumors. We re...

Yeongseok Hwang, Subin Heo, Y. Yoon et al. · 0 citations
Open access Aug 2026

Impact of Cirrhosis Outcome Risk Estimator (CORE) Risk Score on Prognosis Following Hepatectomy for Hepatocellular Carcinoma

Background/Aim: Several studies have reported the clinical value of prognostic markers in patients with hepatocellular carcinoma (HCC). However, no study has examined the clinical significance of the Cirrhosis Outcome Risk Estimator (CORE) risk score on outcomes. This study aimed to investigate the impact of CORE risk...

K. Takagi, Takeyoshi Nishiyama, Jiro Kimura et al. · 0 citations
Aug 2026

[Single-center analysis of surgery and prognosis in 927 patients with hepatocellular carcinoma at CNLC stages Ⅰa to Ⅲa].

Surgical treatment is an important means of achieving long-term survival in patients with HCC, and patients with microvascular invasion, maximum tumor diameter>5 cm, or multiple tumors had significantly better DFS in the adjuvant TACE group than in the non-adjuvant TACE group(all P<0.05).

Q.-X. Diao, Z.-P. Li, Z.-Y. Wang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.